• Can I do this test at home?

    Yes you can do the test at home. The woman performs the collection in the privacy of her own home.

    The complete SoloPap™ process follows the identical path for the vial being picked up from the clinician, laboratory reporting, payment, etc. The only difference is who actually turns the collection device (patient with SoloPap™ and clinician if sample is collected at a medical centre) but after, that the process is identical in every shape/form/cost.

    SoloPap™ gives the individual women the option of having a Paptest when she so chooses, as she is paying the cost of the process and procedure.

    Home diagnosis and monitoring of various disease states has become more prevalent in the past few years. Tests as varied as pregnancy, hemoglobin A1C, HIV and urinalysis testing can be performed in the comfort and privacy of a patient’s home. These new avenues of self-testing can be attributed to patient’s more conscientious role in disease management, busier lifestyles, concern over privacy issues and/or apprehension of undergoing full screening.

  • How much does it cost?

    SoloPap™ Cervical cell collection test is $40. The kit cost does not cover the laboratory testing cost. The laboratory costing in South Australia is $0 and up to $45 depending on the state.

    For HPVDNA testing, the cost is dependent on the NATA approved laboratories per state. Ask your doctor about the advantages of HPVDNA testing.

    The sample collected can be used for HPVDNA testing and a Paptest. Australia is proposing to move to primary HPV testing with reflex liquid based cytology probably in mid-2016. SoloPap™ test procures a specimen totally suitable for this role, HPV testing with reflex cytology, except it has the benefit of being performed solely by the individual woman.

  • Who checks the results?

    The doctor will have the sample transported along with other samples for the laboratory pathology. The LBC vials will be supplied to NATA approved laboratories across Australia by the clinician. These vials will be processed according to the FDA/TGA approved process for LBC vials

    The complete SoloPap™ process follows the identical path for the vial being picked up from the clinician, laboratory reporting, payment, etc. The only difference is who actually turns the collection device (patient with SoloPap™ and clinician if sample collected at a medical centre) but after that the process is identical in every shape/form/cost.

  • How do I get the results?

    The results of the test would be provided to your doctor who would advise the patient of the next steps if positive, etc. The complete SoloPap™ process follows the identical path for the vial being picked up from the clinician, laboratory reporting, payment, etc.

  • 5. What if I have an abnormal result?

    The laboratory results of the test would be provided to the doctor who would advise the patient of the next steps if positive, etc.

  • Why SoloPap™?

    SoloPap™™ is a cervical cell collection device that allows a woman to easily undertake her own cervical cell collection in the privacy of her home. A woman can perform the Paptest procedure in less than ten minutes. The key to the SoloPap™ ease of use is that the traditional speculum has been replaced with a patented cylinder. As a result of its streamlined design, the SoloPap™ speculum can be easily inserted into the vagina without any physician assistance. The patented design allows for a smooth, non-traumatic entry thereby making the cell collection simple, comfortable, and easy to perform. The guide head automatically positions the cervix, allowing the collection brush to retrieve the cell samples. With five rotations of the brush holder the sample is collected and is removed. The cell-laden collection broom is then removed and placed in a container with fixative. The sample is now ready to return to your doctor’s office to be sent to the laboratory. The industry standard cervical brush used by gynecologists worldwide is specially designed to sample both the ectocervical area and the endocervical transition zone, so the patient is screened for the most common types of squamous abnormality.

    Home diagnosis and monitoring of various disease states has become more prevalent in Australia over the last decade. Tests as varied as pregnancy, hemoglobin A1C, HIV and urinalysis testing can be performed in the comfort and privacy of a patient’s home. These new avenues of self-testing can be attributed to patient’s more conscientious role in disease management, busier lifestyles, concern over privacy issues and/or apprehension of undergoing full screening.

  • Is there any other type of testing that can detect cervical disease besides Pap screening?

    NO. The only proven method for the early detection is a Pap test. Since the SoloPap™ kit is proven to return a sample equivalent to a physician-collected specimen, it can be used for both Pap test and HPV screening. The risk of any type of Paptest, including self collection, is the Paptest may not collect the correct cells and may need to be repeated. Please follow SoloPap™ steps and procedures per the instructions included.

  • A routine gynecological (pelvic) exam consists of more than a Pap screening, shouldn't women see a physician as opposed to doing their own Pap screening?

    SoloPap™ is not recommending being a replacement for seeing your doctor, however over 40% of Australian women does not receive a routine pelvic exam or Pap screening as recommended by medical professionals. The SoloPap™ kit enables the medical community to offer Pap screening to those women who would not normally make an appointment with a physician for a routine pelvic exam. SoloPap™ will increase women participation with the medical community and offer them an option to Pap screening.

  • Why would a woman spend money on a self-sampling kit when her annual pelvic exam includes the Pap screening and is covered by insurance?

    40% of Australian women choose not to subject themselves to a routine pelvic exam with a medical professional every two years.

    SoloPap™ has a place in the clinical setting because it is more comfortable for the patient than the traditional speculum. SoloPap™ is ideal for any location without medical facilities. It is not, however, a replacement for a physician’s care and diagnosis.

    SoloPap™ gives a woman an option to be tested as often as she so chooses and provides her full control of the method of testing.

  • How will SoloPap™ be marketed in Australia?

    SoloPap™ Australia will be marketed as follows:

    1. SoloPap™ kits will be supplied via Online and/or Pharmacy Outlets (even Supermarkets)

    2. Packaging will indicate that the kit cost does not cover the laboratory testing. The laboratory costing in South Australia is $0 and up to $45 depending on the state.

    3. Woman performs the collection in the privacy of her own home

    4. The woman visits her health care professional (GP, etc.) or heath centre with the sample collected in the vial and provides that to the doctor or trained medical personnel.

    5. The doctor will have the sample transported along with other samples for the laboratory pathology 

    6. The results of the test would be provided to the doctor who would advise the patient of the next steps if positive, etc.

    7. Pathology lab will bill the woman who pays the pathology for the test directly.

    This method is ideal because:

    • It involves the medical professionals in a manner which they desire
    • The results can be listed on the State’s cervical screening register
    • Confidentiality is maintained at all times
    • The woman/doctor/lab provides the result, follow up, etc.
    • In South Australia LBC is free testing

    Other points

    SoloPap™ kits use FDA/TGA Rovers collection device that is the standard brush used by all leading health professionals in Australia/Globally

    The Rovers collection device is approved for use with LBC by the FDA/TGA

    The LBC vials will be supplied to NATA approved laboratories across Australia by the clinician. These vials will be processed according to the FDA/TGA approved process for LBC vials

    The out of pocket expense for the LBC laboratory test is no different to what a women would pay for clinical collection

    The complete SoloPap™ process follows the identical path for the vial being picked up from the clinician, laboratory reporting, payment, etc. The only difference is who actually turns the collection device (patient with SoloPap™ and clinician if sample collected at the medical centre) but after that the process is identical in every shape/form/cost.

    Clinicians could see the convenience of SoloPap™ and would appeal to many full time working women who find it hard to make time to go to the GP for a Pap test.

    Overcome modesty or cultural issues – self collection would certainly help doctors to overcome issues such as modesty or shame as felt by women from Aboriginal, South Pacific Islander, Maori, Muslim, Asian and other cultures as well as women who have been sexually abused or have medical, physical or mental conditions that stop them from being screened.

  • Why would women be interested in performing their own Pap screening?

    Home diagnosis and monitoring of various disease states has become more prevalent in Australia over the past decade. Tests as varied as pregnancy, hemoglobin A1C, HIV and urinalysis testing can be performed in the comfort and privacy of a patient’s home. These new avenues of self-testing can be attributed to patient’s more conscientious role in disease management, busier lifestyles, concern over privacy issues and/or apprehension of undergoing full screening.

  • Company FAQ

  • How can I advocate SoloPap™ in my community?

    SoloPap™ creates awareness to the need for early detection. If you want to be involved in setting up women advocate groups in your community please contact us.

    We strongly recommend men to be involved in cervical screening by encouraging women in their family to be screened, because men and their families are also affected by the consequences of lack of screening.